Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modelling the hepatitis B vaccination programme in prisons.

A J Sutton1, N J Gay, W J Edmunds

  • 1Health Protection Agency, Modelling and Economics Unit, Colindale, London, UK. Andrew.Sutton@hpa.org.uk

Epidemiology and Infection
|February 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The nexus of immigration regulation and health governance: a scoping review of the extent to which right to access healthcare by migrants, refugees and asylum seekers was upheld in the United Kingdom during COVID-19.

Public health·2024
Same author

Has the HCV cascade of care changed among people who inject drugs in England since the introduction of direct-acting antivirals?

The International journal on drug policy·2024
Same author

Impact analysis of rotavirus vaccination in various geographic regions in Western Europe.

Vaccine·2021
Same author

Enamel Caries Detection and Diagnosis: An Analysis of Systematic Reviews.

Journal of dental research·2021
Same author

The risk of Kawasaki disease after pneumococcal conjugate & meningococcal B vaccine in England: A self-controlled case-series analysis.

Vaccine·2020
Same author

Retrospective assessment of rapid outbreak investigation for gastrointestinal diseases using only cases and background exposure data.

Epidemiology and infection·2020
Same journal

Epidemiological Investigation of a Large Trichinellosis Outbreak in Lebanon, October 2023 - February 2024.

Epidemiology and infection·2026
Same journal

Pandemic preparedness: potential of routine general practice data for infectious disease early signal detection.

Epidemiology and infection·2026
Same journal

ASSOCIATION BETWEEN INTRODUCTION OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE AND BURDEN OF HOSPITALIZED ADULT PNEUMOCOCCAL DISEASE IN TAIWAN - A RETROSPECTIVE DATABASE STUDY.

Epidemiology and infection·2026
Same journal

Using forensic autopsy data to estimate the age-specific infection fatality risk of COVID-19.

Epidemiology and infection·2026
Same journal

Maternal and congenital syphilis in Fiji 2019-2022: a secondary analysis of clinical trial data.

Epidemiology and infection·2026
Same journal

The Socio-economic Shield Limits Lassa Virus Spillover in Urban West Africa.

Epidemiology and infection·2026
See all related articles

A new hepatitis B (HBV) vaccination program in prisons aims to increase coverage for injecting drug users (IDUs). The model predicts significant vaccination increases, highlighting the need for higher reception coverage to protect this vulnerable population.

Area of Science:

  • Public Health
  • Infectious Disease Prevention
  • Epidemiology

Background:

  • Hepatitis B (HBV) infection poses a significant risk, particularly to vulnerable populations like injecting drug users (IDUs).
  • IDUs represent a hard-to-reach demographic for traditional vaccination programs.
  • A prison-based HBV vaccination initiative has been implemented in England and Wales.

Purpose of the Study:

  • To develop a model assessing the impact of a prison-based HBV vaccination program.
  • To predict changes in HBV vaccination coverage among prisoners, ex-prisoners, and IDUs.
  • To evaluate the effectiveness of prison reception vaccination in reaching IDUs.

Main Methods:

  • Development of a mathematical model to simulate vaccination coverage scenarios.

Related Experiment Videos

  • Analysis of predicted changes in vaccination status over time for key populations.
  • Sensitivity analysis based on IDU population size and incarceration duration.

    • Main Results:

    • Baseline HBV vaccination coverage among IDUs in 2012 was predicted at 57%.
    • Coverage could increase to 72% under specific vaccination scenarios.
    • Results are sensitive to the estimated IDU population size and time spent in prison.

    Conclusions:

    • The prison-based HBV vaccination program is a viable strategy for reaching IDUs.
    • Increased vaccination coverage upon prison reception is crucial for program success.
    • The program offers a critical opportunity to reduce HBV infection risk in a high-risk group.